Long Peripheral Catheters First-Line Device For For Multiday IV Therapy In Kids: Study
- byDoctor News Daily Team
 - 07 July, 2025
 - 0 Comments
 - 0 Mins
 
                            
                                    Establishment of functioning peripheral intravenous (IV) access is a vital step to provide care in the emergency and inpatient settings. A recent study suggests that Long Peripheral Catheters (LPCs) reduces catheter failure and total catheters in children and recommend the use of LPCs as the first-line device for peripheral access. The study findings were published in the journal PEDIATRICS on January 14, 2021.
Patients with a medical history of obesity, IV drug abuse (IVDA), end-stage renal disease (ESRD), and/or sickle cell disease have been shown to have Difficult Vascular Access (DVA) using the traditional technique. Once cannulated, the survival time of IV catheters is problematic, with early failure a common complication. In children, intravenous therapy (IVT) is generally administered via peripheral intravenous catheters (PIVCs) (2–6 cm in length). However, a previous study suggests that PIVCs are unreliable after 2 days. Long peripheral catheters (LPCs) (6–15 cm in length) could improve the delivery of IVT, but the data available are limited. Therefore, researchers of Melbourne, Australia, conducted a study to determine if LPCs could decrease catheter failure and the number of catheters in children receiving multiday IVT.
It was an open-label randomized controlled trial conducted at Monash Children's Hospital in Melbourne, Australia. Researchers included 72 participants of age1 to 17 years, undergoing surgery and requiring >48 hours of postoperative IVT. They randomly assigned them to receive either 2.5-cm 22G PIVCs (n=36) or 8-cm 22G LPCs (n=36).
Key findings of the study were:
• Upon analysis, researchers have found a similar median duration of IVT of 5.1 days between the groups.
• They also found that the catheter failure was higher for PIVCs than LPCs (66.7% vs 19.4% or 187.9 vs 41.0 failures per 1000 catheter-days).
• They noted that the infiltration was the most common reason for PIVC failure (33.3% vs 2.8%).
• They found that LPCs exhibited superior life span (4.7 vs 3.5 days) and children with LPCs were twice as likely to complete therapy with a single catheter (80.6% vs 38.9%).
The authors concluded, "LPCs reduce catheter failure and total catheters in children. They should be considered as the first-line device for peripheral access in any child receiving prolonged IVT".
For further information:
https://pediatrics.aappublications.org/content/early/2021/01/13/peds.2020-000877
                                
    Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
    The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
    Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
    If you come across any inconsistencies, please reach out to us at 
    admin@doctornewsdaily.com.
    We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
    By using this website, you agree to our 
    Terms of Use, 
    Privacy Policy, and 
    Advertisement Policy.
    For further details, please review our 
    Full Disclaimer.
Recent News
Gum disease could silently cause serious brain dam...
- 03 November, 2025
 
Can Early-Day Fasting Significantly Boost Metaboli...
- 03 November, 2025
 
Delhi HC bars doctor from running medical centre d...
- 03 November, 2025
 
Phase III data for Gazyva/Gazyvaro show significan...
- 03 November, 2025
 
Daily Newsletter
Get all the top stories from Blogs to keep track.
                    
                    
0 Comments
Post a comment
No comments yet. Be the first to comment!